These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9243358)

  • 1. Interpatient variability: genetic predisposition and other genetic factors.
    West WL; Knight EM; Pradhan S; Hinds TS
    J Clin Pharmacol; 1997 Jul; 37(7):635-48. PubMed ID: 9243358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacogenetics of oxidation reactions of drugs].
    Jacqz-Aigrain E
    Arch Fr Pediatr; 1989 Jan; 46(1):59-65. PubMed ID: 2653266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update: genetic polymorphism of drug metabolizing enzymes in humans.
    Tanaka E
    J Clin Pharm Ther; 1999 Oct; 24(5):323-9. PubMed ID: 10583694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450: genetic polymorphism and drug interactions.
    Belpaire FM; Bogaert MG
    Acta Clin Belg; 1996; 51(4):254-60. PubMed ID: 8858891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic implications of polymorphisms in cytochromes and drug transporters].
    Münster E; Ziegler S; Brunner M
    Wien Med Wochenschr; 2005 Feb; 155(3-4):54-8. PubMed ID: 15791777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From the Viewpoint of Drug Metabolism Research].
    Nakajima M
    Yakugaku Zasshi; 2017; 137(6):697-705. PubMed ID: 28566576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P450 oxidoreductase: genetic polymorphisms and implications for drug metabolism and toxicity.
    Hart SN; Zhong XB
    Expert Opin Drug Metab Toxicol; 2008 Apr; 4(4):439-52. PubMed ID: 18433346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine cytochrome P-450 pharmacogenetics.
    Court MH
    Vet Clin North Am Small Anim Pract; 2013 Sep; 43(5):1027-38. PubMed ID: 23890236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of the cytochromes P450.
    Daly AK
    Curr Top Med Chem; 2004; 4(16):1733-44. PubMed ID: 15579105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
    Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
    J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 polymorphism--molecular, metabolic, and pharmacogenetic aspects. III. Influence of CYP genetic polymorphism on population differentiation of drug metabolism phenotype.
    Tomaszewski P; Kubiak-Tomaszewska G; Łukaszkiewicz J; Pachecka J
    Acta Pol Pharm; 2008; 65(3):319-29. PubMed ID: 18646551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic polymorphisms in drug-metabolizing enzymes].
    Saruwatari J; Nakagawa K; Ishizaki T
    Nihon Rinsho; 2002 Jan; 60(1):58-63. PubMed ID: 11808340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug metabolizing enzymes related to laboratory medicine: cytochromes P-450 and UDP-glucuronosyltransferases.
    Batt AM; Magdalou J; Vincent-Viry M; Ouzzine M; Fournel-Gigleux S; Galteau MM; Siest G
    Clin Chim Acta; 1994 May; 226(2):171-90. PubMed ID: 7923812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic differences in drug disposition.
    May DG
    J Clin Pharmacol; 1994 Sep; 34(9):881-97. PubMed ID: 7983231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of pharmacogenetics on drug disposition and response.
    Eichelbaum M; Evert B
    Clin Exp Pharmacol Physiol; 1996; 23(10-11):983-5. PubMed ID: 8911746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of drug-metabolizing enzymes in Italian populations.
    Serpe L; Canaparo R; Scordo MG; Spina E
    Drug Metab Pers Ther; 2015 Jun; 30(2):107-20. PubMed ID: 25527811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular basis of polymorphic drug metabolism.
    Daly AK
    J Mol Med (Berl); 1995 Nov; 73(11):539-53. PubMed ID: 8751138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics.
    Brosen K
    Clin Pharmacokinet; 1990 Mar; 18(3):220-39. PubMed ID: 2182263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.